Isolation of acetylcholinesterase inhibitory alkaloids from Nerine bowdenii

Natural Product Research

Volumn 24, Issue 3, 2010, Pages 222-225

  Van Rijn, Richard M ^a   Rhee, In K ^a   Verpoorte, Robert ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Acetylcholinesterase inhibitors; Amaryllidaceae; Nerine bowdenii

Indexed keywords

11 O ACETYLAMBELLINE; ACETYLCHOLINESTERASE; AMARYLLIDACEAE ALKALOID; CHOLINESTERASE INHIBITOR; FILOFILINE; NERINE BOWDENII EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; BRUNSVIGIA JOSEPHINEA; DRUG ISOLATION; DRUG STRUCTURE; MEDICINAL PLANT; NERINE BOWDENII; NERINE FILIFOLIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE;

ALKALOIDS; CHOLINESTERASE INHIBITORS; LILIACEAE; MOLECULAR STRUCTURE; PLANT ROOTS;

AMARYLLIDACEAE; BRUNSVIGIA; NERINE BOWDENII; NERINE FILIFOLIA;

EID: 76949108840     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786410802263758     Document Type: Article

References (13)

1. Bartus, R.T., Dean, R.L., Pontecorvo, M.J., & Flicker, C. (1985). The cholinergic hypothesis: A historical overview, current perspective, and future directions. Annals of the New York Academy of Sciences, 444, 332-358.
2. Cassels, B.K., Bermudez, I., Dajas, F., Abin-Carriquiry, J.A., & Wonnacott, S. (2005). From ligand design to therapeutic efficacy: The challenge for nicotinic receptor research. Drug Discovery Today, 10(23-24), 1657-1665.
3. Gabrielsen, B., Monath, T.P., Huggins, J.W., Kefauver, D.F., Pettit, G.R., Groszek, G., et al. (1992). Antiviral (RNA) activity of selected Amaryllidaceae isoquinoline constituents and synthesis of related substances. Journal of Natural Products, 55(11), 1569-1581.
4. Gauthier, S. (2001). Alzheimer's disease: Current and future therapeutic perspectives. Progress in Neuropsychopharmacology and Biological Psychiatry, 25(1), 73-89.
5. Geerts, H. (2005). Indicators of neuroprotection with galantamine. Brain Research Bulletin, 64(6), 519-524.
6. Ingkaninan, K., de Best, C.M., Van der Heijden, R., Hofte, A.J., Karabatak, B., Irth, H., et al. (2000). High-performance liquid chromatography with on-line coupled UV, mass spectrometric and biochemical detection for identification of acetylcholinesterase inhibitors from natural products. Journal of Chromatography A, 872(1-2), 61-73.
7. Likhitwitayawuid, K., Angerhofer, C.K., Chai, H., Pezzuto, J.M., Cordell, G.A., & Ruangrungsi, N. (1993). Cytotoxic and antimalarial alkaloids from the bulbs of Crinum amabile. Journal of Natural Products, 56(8), 1331-1338.
8. Lopez, S., Bastida, J., Viladomat, F., & Codina, C. (2002). Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts. Life Sciences, 71(21), 2521-2529.
9. Oddo, S., & LaFerla, F.M. (2006). The role of nicotinic acetylcholine receptors in Alzheimer's disease. Journal of Physiology, Paris, 99(2-3), 172-179.
10. Rhee, I.K., van de Meent, M., Ingkaninan, K., & Verpoorte, R. (2001). Screening for acetylcholinesterase inhibitors from Amaryllidaceae using silica gel thin-layer chromatography in combination with bioactivity staining. Journal of Chromatography A, 915(1-2), 217-223.
11. Rhee, I.K., van Rijn, R.M., & Verpoorte, R. (2003). Qualitative determination of false-positive effects in the acetylcholinesterase assay using thin layer chromatography. Phytochemical Analysis, 14(3), 127-131.
12. Sabbagh, M.N., Lukas, R.J., Sparks, D.L., & Reid, R.T. (2002). The nicotinic acetylcholine receptor, smoking, and Alzheimer's disease. Journal of Alzheimers Disease, 4(4), 317-325.
13. Viegas Jr, C., Bolzani Vda, S., Barreiro, E.J., & Fraga, C.A. (2005). New anti-Alzheimer drugs from biodiversity: The role of the natural acetylcholinesterase inhibitors. Mini Reviews in Medicinal Chemistry, 5(10), 915-926.